VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AMLChristoph Röllig, Leo Ruhnke, Christoph Schliemann et al.|Annals of Hematology|2025Cited by 4
P554: RESULTS OF A RANDOMIZED PLACEBO-CONTROLLED PHASE 2 STUDY OF HYPOMETHYLATING AGENTS WITH OR WITHOUT ELTROMBOPAG IN ELDERLY AML PATIENTS (DELTA)Katja Sockel, Uwe Platzbecker, Kerstin Schaefer‐Eckart et al.|HemaSphere|2023Cited by 0
Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo‐Controlled Phase 2 <scp>DELTA</scp> TrialKatja Sockel, Uwe Platzbecker, Christoph Röllig et al.|American Journal of Hematology|2025Cited by 0